are you ready to begin your weight-loss journey?

Weight-Loss program

Now offering a non-stimulant approach to medically management weight-loss with semaglutide and tirzepatide

START TODAY

TIRZEPATIDE

STARTING AT $450/MONTH

Tirzepatide is a dual-action treatment that targets both the glucose-dependent insulinotropic polypeptide (GlP) and glucagon-like peptide-1 (GLP-1) receptors to aid in weight-loss and metabolic health.
Start your tirzepatide therapy today!

Tier One

for patients in the initial stages of their treament plan

$450/month

  • Weight-loss management
  • Primary care
  • 2.5mg/wk – 7.5mg/wk
start now

Tier two

for patients that have be prescribed 10mg – 12.5mg of tirzepatide weekly

$600/month

  • Weight-loss management
  • Primary care
  • 10mg/wk – 12.5mg/wk
start now

Tier three

Designed for patients on the highest weekly dose of tirzepatide

$700/month

  • Weight-loss management
  • Primary care
  • 15mg/wk
start now

FAQs

Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management.

Yes. There is a 3 month commitment. We have set this as a standard for our program to ensure that patients are committed to the program. It may take 3 months or more for patient’s to establish a predictable weight-loss trend.

tirzepatide is a safe medication when taken as prescribed and under the supervision of a health care provider. However, some side effects may occur. Common side effects include: nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain.

These are not all the side effects. contact your healthcare provider if you experience any side effects. read more here.

Tirzepatide is a medication prescribed for diabetes and medically managed weight loss. You should not take this medication if you do not have a hemoglobin a1c of 5.7, or a BMI greater than 27 with co-morbidities or a BMI greater than 30.
Tirzepatide is contraindicated for patients who have a personal or family history of medullary thyroid cancer or who have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
There can also be increased complications in patients who have a history of acute pancreatitis, acute gallbladder disease, hypoglycemia, acute kidney injury, diabetic retinopathy, suicidal thoughts or ideations, or allergic reaction to Semaglutide. read more here.

Semaglutide requires refrigeration. Please refrigerate your medication promptly after receiving it.

SEMAGLUTIDE

STARTING AT $350/MONTH

Semaglutide is designed to support weight-loss and improve over all metabolic health.
Get started with semaglutide today!

learn more